Caredx fosters transplant innovation as distinguished founder's circle sponsor for the 23rd annual american society of transplant surgeons state of the art winter symposium

Brisbane, calif.--( business wire )--caredx, inc. (nasdaq: cdna), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers -- today announced its leading participation and top spot, for the fourth consecutive year, as a distinguished founder's circle sponsor for the 23rd annual asts (american society of transplant surgeons) state of the art winter symposium, taking place january 12-15, in miami, florida.
CDNA Ratings Summary
CDNA Quant Ranking